Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Mersen Pharmaceutical Technology Development is a specialized pharmaceutical service provider and Contract Research Organization (CRO) based in Beijing, China. Established in 2004, the company focuses on providing regulatory affairs consulting, drug registration services, and clinical trial management for both domestic and international pharmaceutical clients. It plays a significant role in assisting foreign life science companies with navigating the Chinese regulatory environment and securing approvals from the National Medical Products Administration (NMPA). The firm also facilitates pharmaceutical technology transfers and provides strategic market entry consulting. Its expertise supports the development and commercialization of a wide range of therapeutic products including small molecules and biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京梅尔森医药技术开发.